Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 94813 · Class II · Oklahoma Blood Institute
Key facts
| Event ID | 94813 |
|---|---|
| Recall numbers | B-0420-2024 |
| Recalling firm | Oklahoma Blood Institute |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Apheresis Platelet product, collected in a manner that compromises the sterility of the collection system, was distributed. |
| Initiation date | May 2, 2024 |
| Report date | Aug 7, 2024 |
| Termination date | Jul 26, 2024 |
| City | Oklahoma City |
| State | OK |
| Country | United States |
| FEI number | 1626009 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: